Holland & Hart adds high-stakes patent litigation team from Ashurst Perkins Coie
Less than a month after the merger between Ashurst and Perkins Coie, the new team brings expertise in high-stakes patent matters—including medtech and biotech—in the US.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com
12 October 2026 Ouro Preto Paranhos has brought in a licensed pharmacist with more than 26 years of intellectual property experience to lead the patent practice at the Rio de Janeiro firm.
8 October 2026 The firm has snapped up IP partners from Sheridan Ross as it ramps up its presence in Denver and targets growing demand from life sciences and technology clients.
6 October 2026 The new partner advises technology and life sciences companies in Section 337 investigations and related patent disputes, drawing on extensive private practice and government experience.